PDF(Pubmed)
Abstract：
BACKGROUND: Pharmacists play a key role in community gout education. We investigated pharmacist knowledge of gout management and developed an educational intervention which was assessed in a cohort of Irish pharmacists.
METHODS: A ten-question questionnaire about gout management was developed to assess pharmacists\' knowledge. A 14 min 26 s video educational intervention was co-designed by a rheumatologist, a pharmacist, and designer of pharmacy education resources. The effectiveness of this pharmacy-specific intervention was assessed using the same questionnaire in 53 pharmacists (25 in the intervention group; 28 in the control group). Contingency tables were used to analyse differences between groups.
RESULTS: There were 173 pharmacist respondents to the initial survey; 35.3% answered that first-line therapy for gout involves a combination of a xanthine oxidase inhibitor (e.g., allopurinol) combined with a prophylactic agent (e.g., colchicine), and 28.9% of respondents answered that colchicine prophylaxis should be used when initiating urate-lowering therapy. Following the educational intervention, pharmacist\'s knowledge about gout management increased across many domains, including serum urate targets when using urate-lowering therapy (p = 0.006), use of colchicine prophylaxis (p = 0.011), and duration of colchicine use (p < 0.001).
CONCLUSIONS: Gout management recommendations can be impeded if translation into pharmacy practice is neglected. Pharmacists are a valuable information resource for patients. Co-designing a brief education intervention with pharmacists is an effective, low-cost way to increase pharmacist knowledge on the management of gout.
METHODS: A ten-question questionnaire about gout management was developed to assess pharmacists\' knowledge. A 14 min 26 s video educational intervention was co-designed by a rheumatologist, a pharmacist, and designer of pharmacy education resources. The effectiveness of this pharmacy-specific intervention was assessed using the same questionnaire in 53 pharmacists (25 in the intervention group; 28 in the control group). Contingency tables were used to analyse differences between groups.
RESULTS: There were 173 pharmacist respondents to the initial survey; 35.3% answered that first-line therapy for gout involves a combination of a xanthine oxidase inhibitor (e.g., allopurinol) combined with a prophylactic agent (e.g., colchicine), and 28.9% of respondents answered that colchicine prophylaxis should be used when initiating urate-lowering therapy. Following the educational intervention, pharmacist\'s knowledge about gout management increased across many domains, including serum urate targets when using urate-lowering therapy (p = 0.006), use of colchicine prophylaxis (p = 0.011), and duration of colchicine use (p < 0.001).
CONCLUSIONS: Gout management recommendations can be impeded if translation into pharmacy practice is neglected. Pharmacists are a valuable information resource for patients. Co-designing a brief education intervention with pharmacists is an effective, low-cost way to increase pharmacist knowledge on the management of gout.
摘要：
背景：药剂师在社区痛风教育中起着关键作用。我们调查了药剂师对痛风管理的知识，并开发了一种教育干预措施，并在爱尔兰药剂师队列中进行了评估。
方法：开发了关于痛风管理的十项问卷，以评估药剂师的知识。一个14分26秒的视频教育干预是由风湿病学家共同设计的，药剂师,药学教育资源的设计者。在53名药剂师（干预组25名；对照组28名）中，使用相同的问卷评估了该药学特定干预措施的有效性。使用应急表分析组间差异。
结果：初次调查有173名药剂师受访者；35.3％的人回答说，痛风的一线治疗涉及黄嘌呤氧化酶抑制剂的组合（例如，别嘌呤醇)与预防剂(例如，秋水仙碱)，28.9%的受访者回答在开始降尿酸治疗时应该使用秋水仙碱预防。在教育干预之后，药剂师关于痛风管理的知识在许多领域都有所增加，包括使用降尿酸治疗时的血清尿酸目标（p=0.006），使用秋水仙碱预防（p=0.011），和使用秋水仙碱的持续时间（p<0.001）。
结论：如果忽略转化为药学实践，痛风管理建议可能会受到阻碍。药师是患者宝贵的信息资源。与药剂师共同设计一个简短的教育干预措施是一种有效的，以低成本的方式增加药师对痛风管理的认识。
方法：开发了关于痛风管理的十项问卷，以评估药剂师的知识。一个14分26秒的视频教育干预是由风湿病学家共同设计的，药剂师,药学教育资源的设计者。在53名药剂师（干预组25名；对照组28名）中，使用相同的问卷评估了该药学特定干预措施的有效性。使用应急表分析组间差异。
结果：初次调查有173名药剂师受访者；35.3％的人回答说，痛风的一线治疗涉及黄嘌呤氧化酶抑制剂的组合（例如，别嘌呤醇)与预防剂(例如，秋水仙碱)，28.9%的受访者回答在开始降尿酸治疗时应该使用秋水仙碱预防。在教育干预之后，药剂师关于痛风管理的知识在许多领域都有所增加，包括使用降尿酸治疗时的血清尿酸目标（p=0.006），使用秋水仙碱预防（p=0.011），和使用秋水仙碱的持续时间（p<0.001）。
结论：如果忽略转化为药学实践，痛风管理建议可能会受到阻碍。药师是患者宝贵的信息资源。与药剂师共同设计一个简短的教育干预措施是一种有效的，以低成本的方式增加药师对痛风管理的认识。
